Wanjia Group Holdings Ltd 2019 SR
The report highlights Wanjia Group's sustainability efforts for the 2018/2019 fiscal year, focusing on pharmaceutical wholesale and distribution in China. Key achievements include optimizing logistics routes to minimize fuel consumption and implementing a comprehensive quality management system for drug safety. The company conducted a materiality assessment to align with stakeholder interests and reported a total of 1,554 tCO2e in greenhouse gas emissions. Social initiatives featured community health events, such as a Free Clinic Day and a campaign for collecting expired medications.
Company: Wanjia Group Holdings Ltd
Sector: Health Care
Country: Hong Kong
Year: 2019
Type: SR
Pages: 20
Wanjia Group Holdings Ltd
ESG Report
The report highlights Wanjia Group's sustainability efforts for the 2018/2019 fiscal year, focusing on pharmaceutical wholesale and distribution in China. Key achievements include optimizing logistics routes to minimize fuel consumption and implementing a comprehensive quality management system for drug safety. The company conducted a materiality assessment to align with stakeholder interests and reported a total of 1,554 tCO2e in greenhouse gas emissions. Social initiatives featured community health events, such as a Free Clinic Day and a campaign for collecting expired medications.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Total Waste
Workplace Fatalities
Employees